Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy

Author： Cefalu William T.   Bohannon Nancy J. V.   Edwin Fineberg S.   Teeter John G.   Schwartz Pamela F.   Reis Joann M.   Krasner Alan S.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.11, 2008-11, pp. : 3073-3083

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension

By  

Respiration, Vol. 89, Iss. 6, 2015-06 ,pp. : 515-524

Karger

Access to resources Recommend Favorite

Long‐term efficacy of biofeedback therapy in patients with dyssynergic defecation: results of a median 44 months follow‐up

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 6, 2015-06 ,pp. : 787-795

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term effects of inhaled bronchodilators in stable chronic obstructive pulmonary disease

By Antoniu Sabina A  

Therapy, Vol. 8, Iss. 4, 2011-07 ,pp. : 431-441

Future Medicine

Access to resources Recommend Favorite

Long-Term Inhaled Nitric Oxide plus Dipyridamole for Pulmonary Arterial Hypertension

By  

Respiration, Vol. 72, Iss. 4, 2005-07 ,pp. : 419-422

Karger

Access to resources Recommend Favorite

Long-Term Bronchodilator Inhaled Therapy in COPD: The Role of Tiotropium Bromidum

By  

Reviews on Recent Clinical Trials, Vol. 4, Iss. 2, 2009-05 ,pp. : 89-98

Bentham Science Publishers

Access to resources Recommend Favorite